Andrew Spitzer Materials 1

Andrew Spitzer Materials 1

This presentation will provide an overview of the data supporting Triamcinolone Acetonide Extended Release as a fundamentally new, different and superior injectable for knee osteoarthritis. The novel delivery system of a PLGA microsphere nanoparticle establishes sustained levels of intraarticular steroid with a minimum of systemic absorption. The low systemic concentration has virtually no impact on plasma glucose levels in diabetics. The clinical impact is dramatic, with statistically and clinically meaningful improvements in WOMAC A,B,C, KOOS QOL, and the need for rescue medication versus placebo and Standard Triamcinolone Acetonide.

Share

Recent Comments

    Archives

    About Our Blog

    Iterative approaches to corporate strategy foster collaborative thinking to further the overall value proposition.

    Recent Posts

      Orthopaedic Summit

      35 Mayflower Avenue
      Unit B
      Stamford, CT 06906
      Phone +1 (212) 987-OSET (6738)

      CONTACT US

      SUBSCRIBE

      Follow Us


       
      For the latest news and announcements follow the Orthopaedic Summit social media pages.

      Register

      14th Orthopaedic Summit 2024
      The Fontainebleau Las Vegas
      September 14th – 18th, 2024

      Please click here if you need to reset your password.